Invention Grant
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
-
Application No.: US15599319Application Date: 2017-05-18
-
Publication No.: US09855213B2Publication Date: 2018-01-02
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan Laycock Gilmore
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K47/48 ; A61K31/675
Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as complex regional pain syndrome.
Public/Granted literature
Information query
